Issue: June 2012
May 25, 2012
1 min read
Save

School-entry requirements key in boosting adolescent vaccination compliance

Issue: June 2012
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Sending parents educational materials about necessary adolescent vaccinations does not lead to compliance as effectively as school-entry requirements, according to study results published online.

Erin Bugenske, MPH, and colleagues at the CDC’s National Center for Immunization and Respiratory Diseases reviewed vaccine school-entry requirements or education for 50 states and the District of Columbia for the 2008-2009 school year to measure immunization rates. The researchers focused on three vaccinations recommended for adolescents: tetanus and diphtheria toxoids or tetanus-diphtheria-acellular pertussis, meningococcal conjugate (MenACWY; Menveo, Novartis), and HPV vaccines. Researchers used data from the 2008-2009 National Immunization Survey – Teen.

Bugenske and colleagues said 32 states had Td/Tdap vaccine school-entry requirements and none had Td/Tdap education requirements; three states required MenACWY vaccine and 10 others required education; one state required HPV vaccine and five required education about this vaccine.

Immunization rates were significantly higher where vaccination was required for school entry: MenACWY was 71% compared with 53%, and Td/Tdap was 80% compared with 70%. States with new and pre-existing school-entry vaccine requirements also had a significant increase in coverage when compared with states with no requirements. 

The researchers recommended further evaluation of education requirements, “including distribution methods, message content, and influence on parental attitudes … to ensure that states are utilizing resources effectively.”

Disclosure: Ms. Bugenske reports no relevant financial disclosures.